Trade BNTC stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Benitec Biopharma Inc. (BNTC) is trading at US$8.87, up 1.37% today as of Oct 9, 16:00 EDT. The company has a market capitalisation of US$463.1M. Over the past 52 weeks, BNTC has traded between US$8.52 and US$16.76. On Syfe you can trade BNTC with $0 commission and add it to your watchlist.
| Previous close | US$8.75 |
|---|---|
| Market cap | US$463.1M |
| 52-week range | US$8.52 – US$16.76 |
| Volume | 73.04K |
| Exchange | US |
Benitec Biopharma Inc.
Benitec Biopharma, Inc. is a development-stage biotechnology company, which engages in the advancement of novel genetic medicines. The firm's proprietary platforms include DNA-directed RNA interference, or ddRNAi, combines RNA interference, or RNAi, with gene therapy to create medicines that facilitates sustained silencing of disease-causing genes following a single administration. It is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy and Chronic Hepatitis B. The company was founded in 1995 and is headquartered in Hayward, CA.
Year: 2012
Wedbush Initiates Benitec Biopharma at Outperform With $16 Price Target
Jul 28, 10:46 AM · MT Newswires
Benitec Biopharma Inc. (BNTC) stock is trading at US$8.87, +1.37% from the previous close of US$8.75.
The market cap for Benitec Biopharma Inc. (BNTC) stock is approximately US$463.1M.
The 52-week high for Benitec Biopharma Inc. (BNTC) stock is US$16.76.
The 52-week low for Benitec Biopharma Inc. (BNTC) stock is US$8.52.
Benitec Biopharma Inc. (BNTC) does not currently pay a dividend.
Stay on top of BNTC
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
